Abstract

Research Article

COVID-19 disease with persistently negative RT-PCR test for SARS-CoV-2

Sánchez Ríos Carla Paola*, Jiménez Cabrera Oscar Gabriel, Oropeza Lutzow Rebeca, Vázquez Rojas Hazel, Barreto Rodríguez José Omar, Guzmán-Casta Jordi, Guzmán-Huesca Jorge, Riera-Sala Rodrigo and Centeno Sáenz Gustavo Iván

Published: 07 August, 2020 | Volume 4 - Issue 1 | Pages: 006-010

Introduction: The disease outbreak of COVID-19 has had a great clinical and microbiological impact in the last few months. In the preanalytical phase, the collection a sample from of a respiratory tract at the adequate moment and from the correct anatomical site is essential for a rapid and precise molecular diagnosis with a false negative rate of less than 20%.

Materials and methods: We conducted a descriptive study of COVID-19 disease with a persistently negative RT-PCR test in patients seen at the National Institute of Respiratory Diseases (INER) in Mexico City in the period of March through May of 2020. 38 patients were registered with negative RT-PCR test obtained through nasopharyngeal and oropharyngeal swabbing. We evaluated the distribution of data with the Shapiro-Wilk test of normality. The non-parametric data are reported with median. The nominal and ordinal variables are presented as percentages.

Results: The average age of our cohort was 46 years and 52.63% were male (n = 20). Diabetes Mellitus was documented in 34.21% (n = 13) of the patients, Systemic Hypertension in 21.05% (n = 8), Obesity in 31.57% (n = 12) and Overweight in 42.10% (n = 16). Exposure to tobacco smoke was reported in 47.36% (n = 18) of the patients. The median initial saturation of oxygen was 87% at room air. The severity of the disease on admission was: mild 71.05% (n = 27), moderate 21.05% (n = 8) and severe or critical in 7.89% (n = 3) of the cases respectively. 63.15% (n = 24) sought medical care after 6 or more days with symptoms. Lymphopenia was documented in 78.94% (n = 30). Median LDH at the time of admission was 300, being elevated in 63.15% (n = 24) of the cases. The initial tomographic imaging of the chest revealed predominantly ground glass pattern in 81.57% (n = 31) and predominantly consolidation in 18.42% (n = 7). The registered mortality was 15.78% (n = 6).

Conclusion: Patients with COVID-19 and a persistently negative RT-PCR test with fatal outcomes did not differ from the rest of the COVID-19 population since they present with the same risk factors shared by the rest of patients like lymphopenia, comorbidities, elevation of D-Dimer and DHL on admission as well as a tomographic COVID-19 score of severe illness, however we could suggest that the percentage of patients with a mild form of the disease is higher in those with a persistently negative RT-PCR test.

Read Full Article HTML DOI: 10.29328/journal.jprr.1001014 Cite this Article Read Full Article PDF

References

  1. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report—97. Geneva: World Health Organization; 2020.
  2. Wang L, He W, Yu X, Hu D, Bao M, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020; 80: 639-645. PubMed: https://pubmed.ncbi.nlm.nih.gov/32240670/
  3. Masters PS. The molecular biology of coronaviruses. Adv Virus Res. 2006; 66: 193–292. PubMed: https://www.ncbi.nlm.nih.gov/m/pubmed/16877062/
  4. Kang S, Peng W, Zhu Y, Lu S, Zhou M, et al. Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment. Int J Antimicrob Agents. 2020; 55: 105950. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118423/
  5. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5: 536–544. PubMed: https://pubmed.ncbi.nlm.nih.gov/32123347/
  6. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579: 270-273. PubMed: https://pubmed.ncbi.nlm.nih.gov/32015507/
  7. Report S. Novel coronavirus (2019-nCoV) situation report—22. Geneve: World Health Organization. 2020.
  8. World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. Geneva: World Health Organization. 2020. 10–12.
  9. Xu Y, Li X, Zhu B, Liang H, Fang C, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020; 26: 502–505. PubMed: https://pubmed.ncbi.nlm.nih.gov/32284613/
  10. Hindson J. COVID-19: faecal–oral transmission? Nat Rev Gastroenterol Hepatol. 2020; 17: 259. PubMed: https://pubmed.ncbi.nlm.nih.gov/32214231/
  11. Chen N, Zhou M, Dong X, Li X, Yang B, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (Lond Engl) 2020; 395: 507–513. PubMed: https://pubmed.ncbi.nlm.nih.gov/32007143/
  12. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727–733. PubMed: https://pubmed.ncbi.nlm.nih.gov/31978945/
  13. https://www.infosalus.com/salud-investigacion/noticia-estudio-advierte-posibles-falsos-negativos-covid-19-prueba-pcr-20200413183129.html
  14. Fauci AS, Lane HC, Redfield RR. Covid-19-navigating the uncharted. N Engl J Med. 2020; 382: 1268–1269. PubMed: https://pubmed.ncbi.nlm.nih.gov/32109011/
  15. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 80: 656–665. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151416/
  16. Paules CI, Marston HD, Fauci AS. Coronavirus infections-more than just the common cold. JAMA. 2020; 323: 707. PubMed: https://pubmed.ncbi.nlm.nih.gov/31971553/
  17. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol. 2020; 92: 401–402. PubMed: https://pubmed.ncbi.nlm.nih.gov/31950516/
  18. Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem. 2020; 66: 549–555. PubMed: https://pubmed.ncbi.nlm.nih.gov/32031583/
  19. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25: 2000045. PubMed: https://pubmed.ncbi.nlm.nih.gov/31992387/
  20. Loeffelholz MJ, Tang YW. Laboratory diagnosis of emerging human coronavirus infections — the state of the art. Emerg Microbes Infect. 2020; 9: 747–756. PubMed: https://pubmed.ncbi.nlm.nih.gov/32196430/
  21. Chan PK, To WK, Ng KC, Lam RK, Ng TK, et al. 2004. Laboratory diagnosis of SARS. Emerg Infect Dis. 10: 825–831. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323215/
  22. Emery SL, Erdman DD, Bowen MD, Newton BR, Winchell JM, et al. Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis. 2004; 10: 311–316. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322935/
  23. Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020; 24: 20: 411-412. PubMed: https://pubmed.ncbi.nlm.nih.gov/32105638/
  24. Zou L, Ruan F, Huang M, Liang L, Huang H, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020; 382: 1177–1179. PubMed: https://pubmed.ncbi.nlm.nih.gov/32074444/
  25. To KK, Tsang OT, Leung WS, Tam AR, Wu TC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020; 20: 565-574. PubMed: https://pubmed.ncbi.nlm.nih.gov/32213337/
  26. Wolfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; 581: 465-469. PubMed: https://pubmed.ncbi.nlm.nih.gov/32235945/
  27. Kim C, Ahmed JA, Eidex RB, Nyoka R, Waiboci LW, et al. Comparison of nasopharyngeal and oropharyngeal swabs for the diagnosis of eight respiratory viruses by real-time reverse transcription-PCR assays. PLoS One. 2011; 6: e21610. PubMed: https://pubmed.ncbi.nlm.nih.gov/21738731
  28. Wang W, Xu Y, Gao R, Lu R, Han K, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020; 323: 1843-1844. PubMed: https://pubmed.ncbi.nlm.nih.gov/32159775/
  29. Druce J, Garcia K, Tran T, Papadakis G, Birch C. Evaluation of swabs, transport media, and specimen transport conditions for optimal detection of viruses by PCR. J Clin Microbiol. 2012; 50: 1064–1065. PubMed: https://pubmed.ncbi.nlm.nih.gov/22205810/
  30. Li Q, Guan X, Wu P, Wang X, Zhou L, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382: 1199–1207. PubMed: https://pubmed.ncbi.nlm.nih.gov/31995857/
  31. Goff J, Rowe A, Brownstein JS, Chunara R. Surveillance of acute respiratory infections using community-submitted symptoms and specimens for molecular diagnostic testing. PLoS Curr. 2015; 7: PubMed: https://pubmed.ncbi.nlm.nih.gov/26075141/
  32. To KK, Lu L, Yip CC, Poon RW, Fung AM, et al. Additional molecular testing of saliva specimens improves the detection of respiratory viruses. Emerg Microbes Infect. 2017; 6: e49. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520312/
  33. To KK, Tsang OT, Chik-Yan Yip C, Chan KH, Wu TC, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020; 71: 841-843. PubMed: https://pubmed.ncbi.nlm.nih.gov/32047895/
  34. Wang WK, Chen SY, Liu IJ, Chen YC, Chen HL, et al. SARS Research Group of the National Taiwan University/National Taiwan University Hospital. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis. 2004; 10: 1213–1219. PubMed: https://pubmed.ncbi.nlm.nih.gov/15324540/
  35. Yu F, Yan L, Wang N, Yang S, Wang L, et al. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. Clin Infect Dis. 2020. PubMed: https://pubmed.ncbi.nlm.nih.gov/32221523/
  36. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, et al. Singapore 2019 Novel Coronavirus Outbreak Research Team. 3 March 2020. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 323: 1488-1494. PubMed: https://pubmed.ncbi.nlm.nih.gov/32125362/
  37. Zhang W, Du RH, Li B, Zheng XS, Yang XL, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 9: 386–389. PubMed: https://pubmed.ncbi.nlm.nih.gov/32065057/
  38. Cheng PK, Wong DA, Tong LK, Ip SM, Lo AC, et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet. 363: 1699–1700. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112423/
  39. Isakbaeva ET, Khetsuriani N, Beard RS, Peck A, Erdman D, et al. SARS-associated coronavirus transmission, United States. Emerg Infect Dis. 2004; 10: 225–231. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322913/
  40. Leung WK, To KF, Chan PK, Chan HL, Wu AK, et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003; 125: 1011–1017. PubMed: https://pubmed.ncbi.nlm.nih.gov/14517783/
  41. Munster VJ, Koopmans M, van Doremalen N, van Riel D, et al. A novel coronavirus emerging in China—key questions for impact assessment. N Engl J Med. 382: 692–694. PubMed: https://pubmed.ncbi.nlm.nih.gov/319782

Figures:

Figure 1

Figure 1

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More